VanEck Morningstar Wide Moat Value ETF (MVAL)

Assets	$1.44M
Expense Ratio	0.49%
PE Ratio	19.26
Shares Out	175,000
Dividend (ttm)	$0.31
Dividend Yield	0.98%
Ex-Dividend Date	Dec 23, 2024
Payout Ratio	18.96%
1-Year Return	n/a

Volume	100
Open	31.79
Previous Close	31.86
Day's Range	31.79 - 31.79
52-Week Low	28.89
52-Week High	34.40
Beta	n/a
Holdings	40
Inception Date	Mar 26, 2024

About MVAL

Fund Home Page

The VanEck Morningstar Wide Moat Value ETF (MVAL) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a modified equal-weighted index of 30 to 60 value-oriented US stocks that Morningstar determines to be attractively priced and have sustainable competitive advantages. MVAL was launched on Mar 26, 2024 and is issued by VanEck.

• Asset Class: Equity
• Category: Large Value
• Region: North America
• Stock Exchange: BATS
• Ticker Symbol: MVAL
• ETF Provider: VanEck
• Index Tracked: Morningstar US Broad Value Wide Moat Focus Index

Top 10 Holdings

45.07% of assets

Name	Symbol	Weight
Gilead Sciences, Inc.	GILD	5.63%
Bristol-Myers Squibb Company	BMY	5.37%
The Boeing Company	BA	4.91%
Altria Group, Inc.	MO	4.89%
Kenvue Inc.	KVUE	4.73%
Pfizer Inc.	PFE	4.41%
NXP Semiconductors N.V.	NXPI	4.03%
The Campbell's Company	CPB	3.79%
International Flavors & Fragrances Inc.	IFF	3.74%
Zimmer Biomet Holdings, Inc.	ZBH	3.57%

Dividends

Ex-Dividend	Amount
Dec 23, 2024	$0.313